Shelter Pharma share news and announcements
BSE: 543963Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹47.00.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹75 Cr3,366th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 28 May 2026
- 8.3
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 28 May 2026
- 1.0
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 28 May 2026
- 15.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 28 May 2026
- 0.01
- Volume, BSEVolume. Shares traded on the last trading day.
- 3,000
Shelter Pharma share news and announcements
197 announcements, routine notices left out, newest first. Page 3 of 4.
Sep 2025
Aug 2025
28 Aug · Board meeting
Meeting on 2 Sep 2025: annual general meeting and final dividend8 Aug · Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Selection Of Veterinary Products For Supply To AMUL
6 Aug · Announcement under Regulation 30 (LODR)-Allotment
Jul 2025
4 Jul · Intimation Of Shelter Pharma'S Participation In AYUSH India Expo 2025 Under Regulation 30 Of SEBI Listing Regulations
Jun 2025
26 Jun · Meeting
24 Jun · Board meeting
Meeting on 26 Jun 2025: preferential issue of shares18 Jun · Announcement under Regulation 30 (LODR)-Raising of Funds
16 Jun · Board meeting
Meeting on 18 Jun 2025: issue of warrants and rights issue of equity shares
May 2025
29 May · Non-Applicability Of Regulation 23(9) As Per Regulation 15 Of Chapter IV Of SEBI (LODR) Regulations, 2015 For The Half Year And Year Ended March 2025.
29 May · Results
26 May · Board meeting
Meeting on 29 May 2025: audited results14 May · Announcement Regulation 30 Read With Schedule III Part A Para B Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Mar 2025
Feb 2025
27 Feb · Intimation With Regards To 'Shelter Pharma Limited' Receives A+ Grading In FSSAI Audit Pursuant To Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015
24 Feb · Board meeting
Meeting on 24 Feb 202524 Feb · Management
Jan 2025
8 Jan · Announcement under Regulation 30 (LODR)-Raising of Funds
8 Jan · Corporate Action-Intimation of Right issue
3 Jan · Board meeting
Meeting on 8 Jan 2025: rights issue of equity shares
Dec 2024
Nov 2024
Oct 2024
30 Oct · Non-Applicability Of Regulation 23(9) As Per Regulation 15 Of Chapter IV Of SEBI (LODR) Regulations, 2015 For The Half Year And Year Ended September 2024